Discuss the significance of India-led BRICS BioDesign Programme in strengthening South-South cooperation in healthcare innovation.

The BRICS BioDesign Programme, launched in New Delhi by the Principal Scientific Adviser and led by the Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam, extends India's "BioDesign" need-to-deployment model to BRICS partners [1]. It converts healthcare innovation from a declaratory theme into an operational pillar of South-South cooperation.

Significance for South-South cooperation

• Shared problem-solving: BioDesign begins with clinical need identification, so technologies are designed for high-volume, resource-constrained settings common to the Global South rather than adapted down from Northern markets [1].
• Institutionalisation of cooperation: an exchange of a Memorandum of Agreement and a dedicated BRICS BioDesign Centre give continuity beyond summit rhetoric, building on the earlier BRICS STI Framework Programme, under which DBT and DST ran a joint COVID-19 research call [1][2].
• Affordability and access: the focus on affordable medical devices addresses a structural weakness of developing economies, where dependence on imported high-end equipment raises treatment costs [4].
• Technological self-reliance: India historically imported the bulk of its medical devices; the National Medical Devices Policy, 2023 and the PLI scheme for medical devices target this gap, and BRICS-wide co-development widens markets for such indigenous output [3][4].
• Multi-stakeholder governance model: partnership among the PSA's Office, AMTZ, FICCI and the Science & Technology Cluster links government, state agency, industry and academia — a replicable template for partner countries [1].

Limitations to address

• Outcomes depend on harmonising divergent regulatory and device-approval regimes across member states.
• Intellectual property sharing, financing and manufacturing scale-up remain unsettled; a launch platform is not yet a supply chain.

Thus the programme's real worth lies in shifting BRICS health cooperation from crisis response to sustained co-creation of technology. If backed by regulatory convergence, joint funding and clear IP norms, it can make BRICS a credible source of affordable medtech for the Global South — advancing SDG-3 and India's self-reliance goals together.